BIOMAT Database Logo BIOMAT Database Logo

Low-dose cytosine arabinoside in adult chronic myelomonocytic leukemia. 1987

P Fenaux, and J P Jouet, and F Bauters

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Fenaux, and J P Jouet, and F Bauters
Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
January 1989, Bone marrow transplantation,
P Fenaux, and J P Jouet, and F Bauters
[Low-dose cytosine-arabinoside (Ara-C) therapy for chronic myeloid leukemia].
January 2001, Voprosy onkologii,
P Fenaux, and J P Jouet, and F Bauters
[Low-dose cytosine arabinoside treatment in acute myeloid leukemia].
August 1984, Ugeskrift for laeger,
P Fenaux, and J P Jouet, and F Bauters
Low-dose cytosine arabinoside in relapsed acute lymphocytic leukemia.
January 1990, The American journal of medicine,
P Fenaux, and J P Jouet, and F Bauters
Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia.
February 1989, Cancer,
P Fenaux, and J P Jouet, and F Bauters
Low-dose cytosine arabinoside as remission induction therapy in refractory adult acute lymphocytic leukemia.
April 1989, The American journal of medicine,
P Fenaux, and J P Jouet, and F Bauters
[Low-dose cytosine arabinoside in the treatment of myeloblastic leukemia].
September 1984, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
P Fenaux, and J P Jouet, and F Bauters
Low-dose cytosine arabinoside in the treatment of acute nonlymphocytic leukemia.
January 1988, Acta haematologica,
P Fenaux, and J P Jouet, and F Bauters
Bone pains in chronic myelomonocytic leukaemia, treated by cytosine arabinoside.
June 1978, Annals of the rheumatic diseases,
P Fenaux, and J P Jouet, and F Bauters
High Dose Cytosine Arabinoside in the consolidation of adult acute myeloid leukemia.
April 2012, Mymensingh medical journal : MMJ,
Copied contents to your clipboard!